We can therefore conclude that the HSP90 chaperone bound SRC kinases in ALL cells and that inhibition of HSP90 through the use of the chemical compound NVP-BEP800 has affected the downstream SRC signaling pathways involved in the proliferation and growth of T-ALL and B-ALL cells. This evidence concerns the gene HSP90AA1 and acute lymphoblastic leukemia.